Roundtable Discussion: Dissecting Development of Digital Measures Across CNS Clinical Development

Time: 11:40 am
day: Conference Day Two


Join tables led by digital biomarker experts to discuss the benefits and challenges of different digital measures of neurological disorders.

  • Evaluating retinal eye motion as a prognostic biomarker for patient stratification and granular monitoring in CNS drug development
  • Debating a standardized measurement package to streamline biomarker validation
  • Balancing device and assessment sensitivity and usability to maximize quality of collected data